Dr. Sudha Thiruvengadam, MD

Dr. Thiruvengadam practices at Saint Francis Medical Group in Hartford, Connecticut.

Dr. Thiruvengadam's NPI, 1639433832, was assigned on July 2, 2012. Dr. Thiruvengadam holds Connecticut license 53971.

Dr. Thiruvengadam's primary practice is Saint Francis Medical Group, at 1000 Asylum Ave, Hartford, CT 06105 in Capitol County. The practice phone is (860) 714-1325.

Dr. Thiruvengadam's primary practice is Saint Francis Medical Group in Hartford, Connecticut. Dr. Thiruvengadam is also affiliated with Griffin Hospital. The medical group on file is Trinity Health Of New England Medical Group. Dmand AI also links Dr. Thiruvengadam to 1 more hospital and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thiruvengadam practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Thiruvengadam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Thiruvengadam is licensed in Connecticut.

CMS data shows 974 Medicare services from Dr. Thiruvengadam across 11 procedure codes in 2024, for 178 Medicare patients. Medicare paid $89,912 for them. Every service was in an office.

CMS counts 178 Medicare patients who saw Dr. Thiruvengadam in 2024. The largest group is 75 to 84, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Thiruvengadam's median patient age at 70, with 65% women.

In 2024, Dr. Thiruvengadam wrote 5,216 Medicare Part D claims for 490 patients. 89% of them were for generic drugs. CMS names the drug for 4,647 of them, across 85 drugs with 11 or more claims each, at $348,461 in total drug cost. In 2023, CMS named 4,840 claims across 88 drugs.

Dr. Thiruvengadam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thiruvengadam as offering telehealth.

Dmand AI links 2 papers to Dr. Thiruvengadam in 2021. 2021 was the busiest year, with 2. Dr. Thiruvengadam has published most often in Dis Mon. Dr. Thiruvengadam's most frequent co-authors are Pooja Luthra, MD and Patricia R. Peter, MD.

CMS Open Payments shows 183 general payments to Dr. Thiruvengadam from 32 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $473.